Literature DB >> 19140736

A conserved active site tyrosine residue of proline dehydrogenase helps enforce the preference for proline over hydroxyproline as the substrate.

Elizabeth L Ostrander1, John D Larson, Jonathan P Schuermann, John J Tanner.   

Abstract

Proline dehydrogenase (PRODH) catalyzes the oxidation of l-proline to Delta-1-pyrroline-5-carboxylate. PRODHs exhibit a pronounced preference for proline over hydroxyproline (trans-4-hydroxy-l-proline) as the substrate, but the basis for specificity is unknown. The goal of this study, therefore, is to gain insight into the structural determinants of substrate specificity of this class of enzyme, with a focus on understanding how PRODHs discriminate between the two closely related molecules, proline and hydroxyproline. Two site-directed mutants of the PRODH domain of Escherichia coli PutA were created: Y540A and Y540S. Kinetics measurements were performed with both mutants. Crystal structures of Y540S complexed with hydroxyproline, proline, and the proline analogue l-tetrahydro-2-furoic acid were determined at resolutions of 1.75, 1.90, and 1.85 A, respectively. Mutation of Tyr540 increases the catalytic efficiency for hydroxyproline 3-fold and decreases the specificity for proline by factors of 20 (Y540S) and 50 (Y540A). The structures show that removal of the large phenol side chain increases the volume of the substrate-binding pocket, allowing sufficient room for the 4-hydroxyl of hydroxyproline. Furthermore, the introduced serine residue participates in recognition of hydroxyproline by forming a hydrogen bond with the 4-hydroxyl. This result has implications for understanding the substrate specificity of the related enzyme human hydroxyproline dehydrogenase, which has serine in place of tyrosine at this key active site position. The kinetic and structural results suggest that Tyr540 is an important determinant of specificity. Structurally, it serves as a negative filter for hydroxyproline by clashing with the 4-hydroxyl group of this potential substrate.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19140736      PMCID: PMC2665022          DOI: 10.1021/bi802094k

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  34 in total

Review 1.  Flavoenzymes: diverse catalysts with recurrent features.

Authors:  M W Fraaije; A Mattevi
Journal:  Trends Biochem Sci       Date:  2000-03       Impact factor: 13.807

2.  A compelling genetic hypothesis for a complex disease: PRODH2/DGCR6 variation leads to schizophrenia susceptibility.

Authors:  Aravinda Chakravarti
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-16       Impact factor: 11.205

3.  Electrochemical and functional characterization of the proline dehydrogenase domain of the PutA flavoprotein from Escherichia coli.

Authors:  Madhavan P Vinod; Padmanetra Bellur; Donald F Becker
Journal:  Biochemistry       Date:  2002-05-21       Impact factor: 3.162

Review 4.  Structural biology of proline catabolism.

Authors:  John J Tanner
Journal:  Amino Acids       Date:  2008-03-28       Impact factor: 3.520

5.  Genetic variation at the 22q11 PRODH2/DGCR6 locus presents an unusual pattern and increases susceptibility to schizophrenia.

Authors:  Hui Liu; Simon C Heath; Christina Sobin; J Louw Roos; Brandi L Galke; Maude L Blundell; Marge Lenane; Brian Robertson; Ellen M Wijsman; Judith L Rapoport; Joseph A Gogos; Maria Karayiorgou
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-12       Impact factor: 11.205

6.  Proline oxidase, encoded by p53-induced gene-6, catalyzes the generation of proline-dependent reactive oxygen species.

Authors:  S P Donald; X Y Sun; C A Hu; J Yu; J M Mei; D Valle; J M Phang
Journal:  Cancer Res       Date:  2001-03-01       Impact factor: 12.701

7.  A novel function for hydroxyproline oxidase in apoptosis through generation of reactive oxygen species.

Authors:  Sandra K Cooper; Jui Pandhare; Steven P Donald; James M Phang
Journal:  J Biol Chem       Date:  2008-02-19       Impact factor: 5.157

Review 8.  PRODH variants and risk for schizophrenia.

Authors:  Alecia Willis; Hans Uli Bender; Gary Steel; David Valle
Journal:  Amino Acids       Date:  2008-06-05       Impact factor: 3.520

9.  Oxalate in renal stone disease: the terminal metabolite that just won't go away.

Authors:  Susan R Marengo; Andrea M P Romani
Journal:  Nat Clin Pract Nephrol       Date:  2008-06-03

10.  Structure and kinetics of monofunctional proline dehydrogenase from Thermus thermophilus.

Authors:  Tommi A White; Navasona Krishnan; Donald F Becker; John J Tanner
Journal:  J Biol Chem       Date:  2007-03-07       Impact factor: 5.157

View more
  20 in total

1.  Purification and characterization of Put1p from Saccharomyces cerevisiae.

Authors:  Srimevan Wanduragala; Nikhilesh Sanyal; Xinwen Liang; Donald F Becker
Journal:  Arch Biochem Biophys       Date:  2010-05-05       Impact factor: 4.013

2.  Small-angle X-ray scattering studies of the oligomeric state and quaternary structure of the trifunctional proline utilization A (PutA) flavoprotein from Escherichia coli.

Authors:  Ranjan K Singh; John D Larson; Weidong Zhu; Robert P Rambo; Greg L Hura; Donald F Becker; John J Tanner
Journal:  J Biol Chem       Date:  2011-10-19       Impact factor: 5.157

3.  Geometric restraint drives on- and off-pathway catalysis by the Escherichia coli menaquinol:fumarate reductase.

Authors:  Thomas M Tomasiak; Tara L Archuleta; Juni Andréll; César Luna-Chávez; Tyler A Davis; Maruf Sarwar; Amy J Ham; W Hayes McDonald; Victoria Yankovskaya; Harry A Stern; Jeffrey N Johnston; Elena Maklashina; Gary Cecchini; Tina M Iverson
Journal:  J Biol Chem       Date:  2010-11-23       Impact factor: 5.157

4.  Structural insight into the expanded PCB-degrading abilities of a biphenyl dioxygenase obtained by directed evolution.

Authors:  Pravindra Kumar; Mahmood Mohammadi; Jean-François Viger; Diane Barriault; Leticia Gomez-Gil; Lindsay D Eltis; Jeffrey T Bolin; Michel Sylvestre
Journal:  J Mol Biol       Date:  2010-11-10       Impact factor: 5.469

5.  Crystal structure of the bifunctional proline utilization A flavoenzyme from Bradyrhizobium japonicum.

Authors:  Dhiraj Srivastava; Jonathan P Schuermann; Tommi A White; Navasona Krishnan; Nikhilesh Sanyal; Greg L Hura; Anmin Tan; Michael T Henzl; Donald F Becker; John J Tanner
Journal:  Proc Natl Acad Sci U S A       Date:  2010-02-01       Impact factor: 11.205

6.  Structure and characterization of a class 3B proline utilization A: Ligand-induced dimerization and importance of the C-terminal domain for catalysis.

Authors:  David A Korasick; Thameesha T Gamage; Shelbi Christgen; Kyle M Stiers; Lesa J Beamer; Michael T Henzl; Donald F Becker; John J Tanner
Journal:  J Biol Chem       Date:  2017-04-18       Impact factor: 5.157

7.  First evidence for substrate channeling between proline catabolic enzymes: a validation of domain fusion analysis for predicting protein-protein interactions.

Authors:  Nikhilesh Sanyal; Benjamin W Arentson; Min Luo; John J Tanner; Donald F Becker
Journal:  J Biol Chem       Date:  2014-12-09       Impact factor: 5.157

8.  Proline availability regulates proline-4-hydroxylase synthesis and substrate uptake in proline-hydroxylating recombinant Escherichia coli.

Authors:  Francesco Falcioni; Lars M Blank; Oliver Frick; Andreas Karau; Bruno Bühler; Andreas Schmid
Journal:  Appl Environ Microbiol       Date:  2013-03-01       Impact factor: 4.792

9.  Involvement of the β3-α3 loop of the proline dehydrogenase domain in allosteric regulation of membrane association of proline utilization A.

Authors:  Weidong Zhu; Ashley M Haile; Ranjan K Singh; John D Larson; Danielle Smithen; Jie Y Chan; John J Tanner; Donald F Becker
Journal:  Biochemistry       Date:  2013-06-19       Impact factor: 3.162

10.  Crystal structures and kinetics of monofunctional proline dehydrogenase provide insight into substrate recognition and conformational changes associated with flavin reduction and product release.

Authors:  Min Luo; Benjamin W Arentson; Dhiraj Srivastava; Donald F Becker; John J Tanner
Journal:  Biochemistry       Date:  2012-12-05       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.